abstract |
The present invention relates to 1,4-oxazepines of formula (I) having BACE1 and/or BACE2 inhibitory activity , their preparation, pharmaceutical compositions containing them and their use as therapeutically active substances. The active compounds according to the invention are useful in the therapeutic and/or prophylactic treatment of eg Alzheimer's disease and type 2 diabetes. |